{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:30:51Z","timestamp":1782869451677,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20792-2","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:53:10Z","timestamp":1761126790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of melatonin on advanced glycation end products, inflammation, and oxidative stress in peritoneal dialysis patients: a randomized controlled trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Mina","family":"Movahedian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Tabibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Atabak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Seyrafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Hossein","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"3","key":"20792_CR1","first-page":"151","volume":"51","author":"RG Fassett","year":"2009","unstructured":"Fassett, R. G., Driver, R., Healy, H. & Coombes, J. S. Cardiovascular disease in peritoneal dialysis patients. Panminerva Med. 51(3), 151\u2013161 (2009).","journal-title":"Panminerva Med."},{"issue":"1","key":"20792_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1542-4758.2007.00146.x","volume":"11","author":"DW Johnson","year":"2007","unstructured":"Johnson, D. W., Craven, A. M. & Isbel, N. M. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int. 11(1), 1\u201314 (2007).","journal-title":"Hemodial Int."},{"issue":"4","key":"20792_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000045084","volume":"79","author":"M Bonomini","year":"1998","unstructured":"Bonomini, M. et al. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79(4), 399\u2013407 (1998).","journal-title":"Nephron"},{"issue":"2","key":"20792_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semnephrol.2011.01.005","volume":"31","author":"AY Wang","year":"2011","unstructured":"Wang, A. Y. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 31(2), 159\u2013171 (2011).","journal-title":"Semin Nephrol."},{"issue":"1","key":"20792_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000109397","volume":"28","author":"H Kocak","year":"2008","unstructured":"Kocak, H. et al. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol. 28(1), 91\u201396 (2008).","journal-title":"Am J Nephrol."},{"key":"20792_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1476-511X-9-93","volume":"9","author":"K Mekki","year":"2010","unstructured":"Mekki, K., Taleb, W., Bouzidi, N., Kaddous, A. & Bouchenak, M. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study. Lipids Health Dis. 9, 93 (2010).","journal-title":"Lipids Health Dis."},{"issue":"4","key":"20792_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/ndt\/gfh004","volume":"19","author":"J van de Kerkhof","year":"2004","unstructured":"van de Kerkhof, J. et al. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients. Nephrol Dial Transplant. 19(4), 910\u2013916 (2004).","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"20792_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.jrn.2011.10.019","volume":"22","author":"Y Nishizawa","year":"2012","unstructured":"Nishizawa, Y., Koyama, H. & Inaba, M. AGEs and cardiovascular diseases in patients with end-stage renal diseases. J Ren Nutr. 22(1), 128\u2013133 (2012).","journal-title":"J Ren Nutr."},{"issue":"Suppl 2","key":"20792_CR9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1177\/089686080702702s12","volume":"27","author":"KN Lai","year":"2007","unstructured":"Lai, K. N., Tang, S. C. & Leung, J. C. Mediators of inflammation and fibrosis. Perit Dial Int. 27(Suppl 2), S65\u2013S71 (2007).","journal-title":"Perit Dial Int."},{"issue":"5","key":"20792_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.semnephrol.2004.06.027","volume":"24","author":"S Nakamura","year":"2004","unstructured":"Nakamura, S. & Niwa, T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol. 24(5), 502\u2013505 (2004).","journal-title":"Semin Nephrol."},{"issue":"11","key":"20792_CR11","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/sj.ki.5001506","volume":"69","author":"H Noh","year":"2006","unstructured":"Noh, H. et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int. 69(11), 2022\u20132028 (2006).","journal-title":"Kidney Int."},{"issue":"6","key":"20792_CR12","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1007\/s13197-020-04236-5","volume":"57","author":"J Sangsopha","year":"2020","unstructured":"Sangsopha, J., Johns, N. P., Johns, J. & Moongngarm, A. Dietary sources of melatonin and benefits from production of high melatonin pasteurized milk. J Food Sci Technol. 57(6), 2026\u20132037 (2020).","journal-title":"J Food Sci Technol."},{"issue":"4","key":"20792_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/nu9040367","volume":"9","author":"X Meng","year":"2017","unstructured":"Meng, X. et al. Dietary sources and bioactivities of melatonin. Nutrients 9(4), 367 (2017).","journal-title":"Nutrients"},{"issue":"1","key":"20792_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clnu.2017.12.004","volume":"38","author":"F Raygan","year":"2019","unstructured":"Raygan, F., Ostadmohammadi, V., Bahmani, F., Reiter, R. J. & Asemi, Z. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial. Clinl Nutr. 38(1), 191\u2013196 (2019).","journal-title":"Clinl Nutr."},{"issue":"2","key":"20792_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/scipharm88020028","volume":"88","author":"SJ Abood","year":"2020","unstructured":"Abood, S. J., Abdulsahib, W. K., Hussain, S. A. & Ismail, S. H. Melatonin potentiates the therapeutic effects of metformin in women with metabolic syndrome. Sci Pharm. 88(2), 28 (2020).","journal-title":"Sci Pharm."},{"key":"20792_CR16","doi-asserted-by":"crossref","unstructured":"Jamilian, M., et al. Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 10: 273 (2019).","DOI":"10.3389\/fendo.2019.00273"},{"issue":"1","key":"20792_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.32947\/ajps.v18i1.455","volume":"18","author":"HCA Al Lami","year":"2018","unstructured":"Al Lami, H. C. A. Melatonin improves lipid profile and ameliorates lipid peroxidation in patients with chronic kidney disease. AJPS 18(1), 38\u201345 (2018).","journal-title":"AJPS"},{"key":"20792_CR18","doi-asserted-by":"publisher","first-page":"101241","DOI":"10.1016\/j.trim.2019.101241","volume":"57","author":"F Panah","year":"2019","unstructured":"Panah, F. et al. The effect of oral melatonin on renal ischemia\u2013reperfusion injury in transplant patients: A double-blind, randomized controlled trial. Transpl immunol. 57, 101241 (2019).","journal-title":"Transpl immunol."},{"issue":"3","key":"20792_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.jrn.2019.08.003","volume":"30","author":"V Ostadmohammadi","year":"2020","unstructured":"Ostadmohammadi, V. et al. The effects of melatonin supplementation on parameters of mental health, glycemic control, markers of cardiometabolic risk, and oxidative stress in diabetic hemodialysis patients: a randomized, double-blind, placebo-controlled trial. J Ren Nutr. 30(3), 242\u2013250 (2020).","journal-title":"J Ren Nutr."},{"key":"20792_CR20","doi-asserted-by":"crossref","unstructured":"Burkart, J. & Bargman, J. Adequacy of Peritoneal Dialysis, Including Fluid Balance in Nolph and Gokal\u2019s Textbook of Peritoneal Dialysis (ed. Khanna, R. & Krediet, R.T.) 469\u2013503 (Springer, 2009).","DOI":"10.1007\/978-0-387-78940-8_16"},{"issue":"6","key":"20792_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3747\/pdi.2017.00004","volume":"37","author":"V La Milia","year":"2017","unstructured":"La Milia, V. et al. Ultrafiltration failure assessment (UFFA) study of the Italian Society of Nephrology Peritoneal Dialysis Study Group. Peritoneal equilibration test reference values using a 3.86% glucose solution during the first year of peritoneal dialysis: results of a multicenter study of a large patient population. Perit Dial Int. 37(6), 633\u2013638 (2017).","journal-title":"Perit Dial Int."},{"issue":"3","key":"20792_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1525-139X.1990.tb00029.x","volume":"3","author":"ZJ Twardowski","year":"1990","unstructured":"Twardowski, Z. J. The fast peritoneal equilibration test. Semin Dial. 3(3), 141\u2013142 (1990).","journal-title":"Semin Dial."},{"issue":"2\u20133","key":"20792_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000014381","volume":"17","author":"B Canaud","year":"1999","unstructured":"Canaud, B. et al. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 17(2\u20133), 99\u2013106 (1999).","journal-title":"Blood Purif."},{"issue":"9","key":"20792_CR24","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1007\/s10067-021-05670-2","volume":"40","author":"K Esalatmanesh","year":"2021","unstructured":"Esalatmanesh, K. et al. Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled trial. Clin Rheumatol. 40(9), 3591\u20133597 (2021).","journal-title":"Clin Rheumatol."},{"key":"20792_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/DMSO.S242208","volume":"13","author":"A Zare Javid","year":"2020","unstructured":"Zare Javid, A. et al. Antioxidant and anti-inflammatory properties of melatonin in patients with type 2 diabetes mellitus with periodontal disease under non-surgical periodontal therapy: a double-blind, placebo-controlled trial. Diabetes Metab Syndr Obes. 13, 753\u2013761 (2020).","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"7","key":"20792_CR26","doi-asserted-by":"publisher","first-page":"e14246","DOI":"10.1111\/ijcp.14246","volume":"75","author":"M Nabatian-Asl","year":"2021","unstructured":"Nabatian-Asl, M. et al. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: a randomised, double-blind, placebo-controlled trial. Int J Clin Pract. 75(7), e14246 (2021).","journal-title":"Int J Clin Pract."},{"issue":"1","key":"20792_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11011-024-01428-2","volume":"40","author":"S Jallouli","year":"2024","unstructured":"Jallouli, S. et al. 12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a randomized controlled trial. Metab Brain Dis. 40(1), 52 (2024).","journal-title":"Metab Brain Dis."},{"key":"20792_CR28","doi-asserted-by":"publisher","first-page":"105878","DOI":"10.1016\/j.clineuro.2020.105878","volume":"195","author":"R Daneshvar Kakhaki","year":"2020","unstructured":"Daneshvar Kakhaki, R. et al. Melatonin supplementation and the effects on clinical and metabolic status in Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosurg. 195, 105878 (2020).","journal-title":"Clin Neurol Neurosurg."},{"key":"20792_CR29","doi-asserted-by":"publisher","first-page":"9523923","DOI":"10.1155\/2023\/9523923","volume":"2023","author":"N Azarmehr","year":"2023","unstructured":"Azarmehr, N. et al. Melatonin-attenuated oxidative stress in high-risk pregnant women receiving enoxaparin and aspirin. Evid Based Complement Alternat Med. 2023, 9523923 (2023).","journal-title":"Evid Based Complement Alternat Med."},{"issue":"9","key":"20792_CR30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom10091211","volume":"10","author":"DM Chitimus","year":"2020","unstructured":"Chitimus, D. M. et al. Melatonin\u2019s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules 10(9), 1211 (2020).","journal-title":"Biomolecules"},{"issue":"1","key":"20792_CR31","doi-asserted-by":"publisher","first-page":"C11","DOI":"10.1159\/000314544","volume":"116","author":"KN Lai","year":"2010","unstructured":"Lai, K. N. & Leung, J. C. Inflammation in peritoneal dialysis. Nephron Clin Pract. 116(1), C11\u2013C18 (2010).","journal-title":"Nephron Clin Pract."},{"issue":"1","key":"20792_CR32","first-page":"909373","volume":"2014","author":"Y Cho","year":"2014","unstructured":"Cho, Y., Hawley, C. M. & Johnson, D. W. Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol. 2014(1), 909373 (2014).","journal-title":"Int J Nephrol."},{"key":"20792_CR33","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.ctim.2020.102452","volume":"52","author":"M Bahrami","year":"2020","unstructured":"Bahrami, M. et al. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. Complement Ther Med. 52, 102452 (2020).","journal-title":"Complement Ther Med."},{"issue":"1","key":"20792_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10787-018-0539-0","volume":"27","author":"H Bazyar","year":"2019","unstructured":"Bazyar, H. et al. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial. Inflammopharmacology 27(1), 67\u201376 (2019).","journal-title":"Inflammopharmacology"},{"key":"20792_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2277-9175.204593","volume":"6","author":"H Pakravan","year":"2017","unstructured":"Pakravan, H. et al. The Effects of Melatonin in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Adv Biomed Res. 6, 40 (2017).","journal-title":"Adv Biomed Res."},{"issue":"7","key":"20792_CR36","first-page":"504","volume":"47","author":"N Mesri Alamdari","year":"2015","unstructured":"Mesri Alamdari, N. et al. A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women. Horm Metab Res. 47(7), 504\u2013508 (2015).","journal-title":"Horm Metab Res."},{"issue":"Suppl1","key":"20792_CR37","first-page":"258","volume":"18","author":"A Farrokhian","year":"2019","unstructured":"Farrokhian, A. et al. Effect of bedtime melatonin administration in patients with type 2 diabetes: a triple-blind, placebo-controlled, randomized trial. Iran J Pharm Res. 18(Suppl1), 258\u2013268 (2019).","journal-title":"Iran J Pharm Res."},{"issue":"3","key":"20792_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.31083\/j.fbl2703105","volume":"27","author":"A Shaito","year":"2022","unstructured":"Shaito, A. et al. Oxidative stress-induced endothelial dysfunction in cardiovascular diseases. Front Biosci (Landmark Ed). 27(3), 105 (2022).","journal-title":"Front Biosci (Landmark Ed)."},{"key":"20792_CR39","doi-asserted-by":"publisher","first-page":"116140","DOI":"10.1016\/j.biopha.2024.116140","volume":"171","author":"G Xu","year":"2024","unstructured":"Xu, G. et al. The role and therapeutic potential of nuclear factor kappaB (NF-kappaB) in ischemic stroke. Biomed Pharmacother. 171, 116140 (2024).","journal-title":"Biomed Pharmacother."},{"issue":"47","key":"20792_CR40","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black, S., Kushner, I. & Samols, D. C-reactive protein. J Biol Chem. 279(47), 48487\u201348490 (2004).","journal-title":"J Biol Chem."},{"issue":"3","key":"20792_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.32794\/mr112500102","volume":"4","author":"M Dattaab","year":"2021","unstructured":"Dattaab, M., Majumderab, R., Chattopadhyayb, A. & Bandyopadhyayac, D. Protective effect of melatonin in atherosclerotic cardiovascular disease: a comprehensive review. Melatonin Res. 4(3), 408\u2013430 (2021).","journal-title":"Melatonin Res."},{"issue":"4","key":"20792_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.ajkd.2004.12.012","volume":"45","author":"AY Wang","year":"2005","unstructured":"Wang, A. Y. et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis. 45(4), 715\u2013729 (2005).","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"20792_CR43","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/acs.jafc.8b06217","volume":"67","author":"HY Li","year":"2019","unstructured":"Li, H. Y., Leu, Y. L., Wu, Y. C. & Wang, S. H. Melatonin inhibits in vitro smooth muscle cell inflammation and proliferation and atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem. 67(7), 1889\u20131901 (2019).","journal-title":"J Agric Food Chem."},{"issue":"5","key":"20792_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1525-139X.2012.01081.x","volume":"25","author":"SK Mallipattu","year":"2012","unstructured":"Mallipattu, S. K., He, J. C. & Uribarri, J. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Semin Dial. 25(5), 529\u2013538 (2012).","journal-title":"Semin Dial."},{"issue":"1","key":"20792_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2215\/CJN.05350709","volume":"5","author":"NJ McIntyre","year":"2010","unstructured":"McIntyre, N. J. et al. Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol. 5(1), 51\u201355 (2010).","journal-title":"Clin J Am Soc Nephrol."},{"key":"20792_CR46","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3389\/fphys.2018.01815","volume":"9","author":"RT Krediet","year":"2018","unstructured":"Krediet, R. T. Ultrafiltration failure is a reflection of peritoneal alterations in patients treated with peritoneal dialysis. Front Physiol. 9, 1815 (2018).","journal-title":"Front Physiol."},{"key":"20792_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ygcen.2019.04.016","volume":"280","author":"AK Verma","year":"2019","unstructured":"Verma, A. K., Singh, S. & Rizvi, S. I. Redox homeostasis in a rodent model of circadian disruption: Effect of melatonin supplementation. Gen Comp Endocrinol. 280, 97\u2013103 (2019).","journal-title":"Gen Comp Endocrinol."},{"issue":"11","key":"20792_CR48","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/07420528.2020.1792483","volume":"37","author":"AK Verma","year":"2020","unstructured":"Verma, A. K., Singh, S. & Rizvi, S. I. Age-dependent altered redox homeostasis in the chronodisrupted rat model and moderation by melatonin administration. Chronobiol Int. 37(11), 1517\u20131527 (2020).","journal-title":"Chronobiol Int."},{"issue":"4","key":"20792_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10865-019-00100-w","volume":"43","author":"G Cleo","year":"2020","unstructured":"Cleo, G., Beller, E., Glasziou, P., Isenring, E. & Thomas, R. Efficacy of habit-based weight loss interventions: a systematic review and meta-analysis. J Behav Med. 43(4), 519\u2013532 (2020).","journal-title":"J Behav Med."},{"issue":"6925","key":"20792_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/bmj.308.6925.367","volume":"308","author":"MR Law","year":"1994","unstructured":"Law, M. R., Wald, N. J. & Thompson, S. G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ 308(6925), 367\u2013372 (1994).","journal-title":"BMJ"},{"issue":"10022","key":"20792_CR51","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387(10022), 957\u2013967 (2016).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20792-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20792-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20792-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:04:16Z","timestamp":1761131056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20792-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20792"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20792-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36896"}}